GLP-2R Antibodies

Santa Cruz Biotechnology provides a broad selection of GLP-2R monoclonal antibodies for research focused on understanding the glucagon-like peptide-2 receptor. GLP-2R monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The glucagon-like peptide-2 receptor plays a crucial role in regulating intestinal growth and function, as well as influencing nutrient absorption and gut motility. Understanding GLP-2R signaling pathways is essential for exploring therapeutic targets in gastrointestinal disorders and metabolic diseases. The study of GLP-2R is vital for advancing our knowledge of gut-brain interactions and their implications in health and disease. GLP-2R monoclonal antibodies enable precise detection and characterization of receptor expression patterns across different tissues and experimental conditions. Researchers can effectively track GLP-2R localization and examine its interactions with various molecular partners. The exceptional specificity of Santa Cruz Biotechnology monoclonal antibodies supports scientists worldwide in advancing GLP-2R research and developing potential therapeutic strategies.